ArticleInternational journal of endocrinology2012

Genetically engineered islets and alternative sources of insulin-producing cells for treating autoimmune diabetes: quo vadis?

Feng-Cheng Chou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.